A specific RAD51 haplotype increases breast cancer risk in Jewish non-Ashkenazi high-risk women

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Inabr GalEitan Friedman

Abstract

While the precise genes involved in determining familial breast cancer risk in addition to BRCA1/2 are mostly unknown, one strong candidate is RAD51. Jewish non-Ashkenazi women at high-risk for breast/ovarian cancer and ethnically matched controls were genotyped using four single nucleotide polymorphisms spanning the RAD51 genomic region, and the resulting haplotypes were constructed using the GERBIL algorithm. A total of 314 individuals were genotyped: 184 non-Ashkenazi high-risk women (119 with breast cancer), and 130 unaffected, average-risk ethnically matched controls. Using GEBRIL, three frequent haplotypes were constructed. One of the haplotypes (TGTA - coined haplotype 3) was present in 7.3% (19/260 haplotypes) of controls (n=130) and in 16.8% (40/238 haplotypes) of high-risk breast cancer patients (n=119, P=0.001). A specific RAD51 haplotype is more prevalent among non-Ashkenazi Jewish high-risk women than in average-risk population.

References

Feb 1, 1995·Nature Genetics·A G Motulsky
Jun 14, 1996·Biochemical and Biophysical Research Communications·T TakiT Morita
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·T Tsuzuki MoritaT
May 15, 1997·The New England Journal of Medicine·J P StruewingM A Tucker
Dec 31, 1997·Molecular and Cellular Biology·S J XiaR J Shmookler Reis
Mar 24, 1999·Cancer Genetics and Cytogenetics·H T LynchS A Narod
May 12, 2000·Journal of Human Genetics·M KatoY Miki
Aug 30, 2000·International Journal of Cancer. Journal International Du Cancer·K YoshikawaR Takahashi
Nov 28, 2000·International Journal of Cancer. Journal International Du Cancer·H MaackeH W Stürzbecher
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·E Levy-LahadR Gershoni-Baruch
Mar 20, 2001·American Journal of Human Genetics·M StephensP Donnelly
Mar 15, 2003·Nature Reviews. Cancer·Steven A Narod
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Aug 3, 2004·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Gideon Greenspan, Dan Geiger
Aug 24, 2004·Oncogene·Richard S Houlston, Julian Peto
Dec 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Gad Kimmel, Ron Shamir

❮ Previous
Next ❯

Citations

Jul 14, 2010·Breast Cancer Research and Treatment·Guo-Wu ZhouQiang Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Mary E SehlPatricia A Ganz
American Journal of Human Genetics
Antonis C AntoniouConsortium of Investigators of Modifiers of BRCA1/2 (CIMBA)
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Anna JakubowskaUte Hamann
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Anna JakubowskaJan Lubiński
© 2022 Meta ULC. All rights reserved